Pfizer To Open Trial Data to Researchers, Participants
On Wednesday, Pfizer announced plans beginning in 2014 to give independent researchers and patients who participate in studies greater access to the pharmaceutical firm's clinical trial data. Pfizer -- which is the largest pharmaceutical firm in the U.S. -- said it hopes its effort to boost clinical trial data transparency will advance medical research and encourage more patients to participate in clinical trials.
- "Pfizer To Expand Clinical Data Access to Researchers, Patients" (Berkrot, Reuters, 12/4).